Palisade Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,050
| Closed | -$236K | – | 428 |
|
|
2021
Q3 | $236K | Buy |
3,050
+550
| +22% | +$42.6K | 0.01% | 394 |
|
|
2021
Q2 | $209K | Sell |
2,500
-1,000
| -29% | -$83.6K | ﹤0.01% | 393 |
|
|
2021
Q1 | $264K | Buy |
+3,500
| New | +$264K | 0.01% | 360 |
|
|
2020
Q4 | – | Sell |
-3,000
| Closed | -$228K | – | 386 |
|
|
2020
Q3 | $228K | Buy |
+3,000
| New | +$228K | 0.01% | 374 |
|
|
2017
Q1 | – | Sell |
-2,598
| Closed | -$215K | – | 436 |
|
|
2016
Q4 | $215K | Sell |
2,598
-1,333
| -34% | -$110K | 0.01% | 445 |
|
|
2016
Q3 | $364K | Buy |
+3,931
| New | +$364K | 0.01% | 514 |
|
|
2016
Q2 | – | Sell |
-2,429
| Closed | -$200K | – | 539 |
|
|
2016
Q1 | $200K | Sell |
2,429
-85
| -3% | -$7K | 0.01% | 518 |
|
|
2015
Q4 | $263K | Buy |
2,514
+24
| +1% | +$2.51K | 0.01% | 501 |
|
|
2015
Q3 | $262K | Buy |
2,490
+22
| +0.9% | +$2.32K | 0.01% | 499 |
|
|
2015
Q2 | $338K | Buy |
+2,468
| New | +$338K | 0.01% | 493 |
|